Toth Financial Advisory’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11
| Closed | -$56 | – | 797 |
|
|
2024
Q1 | $56 | Buy |
+11
| New | +$56 | ﹤0.01% | 708 |
|
|
2023
Q4 | – | Sell |
-11
| Closed | -$103 | – | 803 |
|
|
2023
Q3 | $103 | Hold |
11
| – | – | ﹤0.01% | 741 |
|
|
2023
Q2 | $236 | Hold |
11
| – | – | ﹤0.01% | 753 |
|
|
2023
Q1 | $301 | Buy |
+11
| New | +$301 | ﹤0.01% | 783 |
|